Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
IMpower010: results from Asian patients in a phase 3 study of adjuvant atezolizumab in resected stage IB-IIIA NSCLC Kenmotsu, H., Zhou, C., Altorki, N., Felip, E., Vallieres, E., Sugawara, S., Sakai, H., Saito, H., Tao, M., Kawaguchi, K., Liu, Y., Yu, C., Wu, Q., Lin, H., Wu, F., Bennett, E., Mcnally, V., Gitlitz, B., Wakelee, H. ELSEVIER. 2022: S464
View details for DOI 10.1016/j.annonc.2022.05.063
View details for Web of Science ID 000834940400148